{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:27:56Z","timestamp":1791160076253,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T00:00:00Z","timestamp":1308960000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00415-011-6146-2","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T20:00:53Z","timestamp":1309032053000},"page":"132-138","source":"Crossref","is-referenced-by-count":51,"title":["A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results"],"prefix":"10.1007","volume":"259","author":[{"given":"Francesco","family":"Sacc\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Quarantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tecla","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Piro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Carotenuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Marsili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Filla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,25]]},"reference":[{"key":"6146_CR1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1056\/NEJM199403033300901","volume":"330","author":"G Bensimon","year":"1994","unstructured":"Bensimon G, Lacomblez L, Meininger V (1994) A controlled trial of riluzole in amyotrophic lateral sclerosis ALS\/Riluzole Study Group. N Engl J Med 330:585\u2013591","journal-title":"N Engl J Med"},{"key":"6146_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2006.02609.x","volume":"65","author":"LL Morselli","year":"2006","unstructured":"Morselli LL, Bongioanni P, Genovesi M et al (2006) Growth hormone secretion is impaired in amyotrophic lateral sclerosis. Clin Endocrinol (Oxf) 65:385\u2013388","journal-title":"Clin Endocrinol (Oxf)"},{"key":"6146_CR3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.49.6.1621","volume":"49","author":"EC Lai","year":"1997","unstructured":"Lai EC, Felice KJ, Festoff BW et al (1997) Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS\/IGF-I Study Group. Neurology 49:1621\u20131630","journal-title":"Neurology"},{"key":"6146_CR4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1212\/WNL.51.2.583","volume":"51","author":"GD Borasio","year":"1998","unstructured":"Borasio GD, Robberecht W, Leigh PN et al (1998) A placebo-controlled trial of insulin-like growth factor-I in amyotrophic lateral sclerosis. European ALS\/IGF-I Study Group. Neurology 51:583\u2013586","journal-title":"Neurology"},{"key":"6146_CR5","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1212\/01.wnl.0000335970.78664.36","volume":"71","author":"EJ Sorenson","year":"2008","unstructured":"Sorenson EJ, Windbank AJ, Mandrekar JN et al (2008) Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology 71:1770\u20131775","journal-title":"Neurology"},{"key":"6146_CR6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/mus.880160608","volume":"16","author":"RA Smith","year":"1993","unstructured":"Smith RA, Melmed S, Sherman B, Frane J, Munsat TL, Festoff BW (1993) Recombinant growth hormone treatment of amyotrophic lateral sclerosis. Muscle Nerve 16:624\u2013633","journal-title":"Muscle Nerve"},{"key":"6146_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13\u201321","journal-title":"J Neurol Sci"},{"key":"6146_CR8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.58.5.773","volume":"58","author":"J Suhy","year":"2002","unstructured":"Suhy J, Miller RG, Rule R et al (2002) Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 58:773\u2013779","journal-title":"Neurology"},{"key":"6146_CR9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"6146_CR10","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ghir.2009.12.003","volume":"20","author":"ND Aberg","year":"2010","unstructured":"Aberg ND, Lind J, Isgaard J, Georg Kuhn H (2010) Peripheral growth hormone induces cell proliferation in the intect adult rat brain. Growth Horm IGF Res 20:264\u2013269","journal-title":"Growth Horm IGF Res"},{"key":"6146_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.20451","volume":"57","author":"BK Kaspar","year":"2005","unstructured":"Kaspar BK, Frost LM, Christian L, Umapathi P, Gage FH (2005) Synergy of Insulin-like growth factor-1 and exercise in amyotrophic lateral sclerosis. Ann Neurol 57:649\u2013655","journal-title":"Ann Neurol"},{"key":"6146_CR12","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar BK, Lladl\u00f2 J, Sherkat N, Rothstein JD, Gage FH (2003) Retrograde viral delivery of IGF-I prolongs survival in a mouse ALS model. Science 301:839\u2013842","journal-title":"Science"},{"key":"6146_CR13","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1210\/jcem.86.11.8019","volume":"86","author":"CK Buckway","year":"2001","unstructured":"Buckway CK, Guevara-Aguirre J, Pratt KL, Burren CP, Rosenfeld RG (2001) The IGF-I generation test revised: a marker of GH sensitivity. JCEM 86:5176\u20135183","journal-title":"JCEM"},{"key":"6146_CR14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1468-1331.2009.02896.x","volume":"17","author":"MT Pellecchia","year":"2010","unstructured":"Pellecchia MT, Pivonello R, Monsurro MR et al (2010) The GH-IGF system in amyotrophic lateral sclerosis: correlations between pituitary GH secretion capacity, insulin-like growth factors and clinical features. Eur J Neurol 17:666\u2013671","journal-title":"Eur J Neurol"},{"key":"6146_CR15","doi-asserted-by":"crossref","unstructured":"Salvatore E, Rinaldi C, Tucci T et al (2011) Growth hormone response to arginine test differentiates between two subgroups of Huntington\u2019s disease patients. J Neurol Neurosurg Psychiatry 82:543\u2013547","DOI":"10.1136\/jnnp.2010.208553"},{"key":"6146_CR16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-510X(84)90154-0","volume":"63","author":"ET Reyes","year":"1984","unstructured":"Reyes ET, Perurena OH, Festoff BW, Joegensen R, Moore WV (1984) Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci 63:317\u2013324","journal-title":"J Neurol Sci"},{"key":"6146_CR17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/17482960902822960","volume":"11","author":"PF Pradat","year":"2010","unstructured":"Pradat PF, Bruneteau G, Gordon PH et al (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:166\u2013171","journal-title":"Amyotroph Lateral Scler"},{"key":"6146_CR18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1212\/WNL.50.3.772","volume":"50","author":"I Torres-Aleman","year":"1998","unstructured":"Torres-Aleman I, Barrios V, Berciano J (1998) The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis. Neurology 50:772\u2013776","journal-title":"Neurology"},{"key":"6146_CR19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1468-1331.2009.02815.x","volume":"17","author":"M Corbo","year":"2010","unstructured":"Corbo M, Lunetta C, Magni P et al (2010) Free insulin-like growth factor (IGF)-1 and IGF-binding proteins-2 and -3 in serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients. Eur J Neurol 17:398\u2013404","journal-title":"Eur J Neurol"},{"key":"6146_CR20","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ghir.2007.06.002","volume":"17","author":"S Hosback","year":"2007","unstructured":"Hosback S, Hardiman O, Nolan CM et al (2007) Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis. Growth Horm IGF Res 17:472\u2013479","journal-title":"Growth Horm IGF Res"},{"key":"6146_CR21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1210\/jc.84.2.553","volume":"84","author":"H Olivecrona","year":"1999","unstructured":"Olivecrona H, Hilding A, Ekstrom C et al (1999) Acute and short-term effects of growth hormone on insulin-like growth factors and their binding proteins: serum levels and hepatic messenger ribonucleic acid responses in humans. J Clin Endocrinol Metab 84:553\u2013560","journal-title":"J Clin Endocrinol Metab"},{"key":"6146_CR22","doi-asserted-by":"crossref","first-page":"39174","DOI":"10.1074\/jbc.M908888199","volume":"275","author":"AJ Butt","year":"2000","unstructured":"Butt AJ, Firth SM, King MA, Baxter RC (2000) Insulin-like growth factor binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 275:39174\u201339181","journal-title":"J Biol Chem"},{"key":"6146_CR23","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1210\/en.2005-1537","volume":"147","author":"L Liao","year":"2006","unstructured":"Liao L, Dearth RK, Zhou S, Britton OL, Lee AV, Xu J (2006) Liver-specific overexpression of the insulin-like growth factor-I enhances somatic growth and partially prevents the effects of growth hormone deficiency. Endocrinology 147:3877\u20133888","journal-title":"Endocrinology"},{"key":"6146_CR24","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2009.02775.x","volume":"17","author":"I Niebroj-Dobosz","year":"2010","unstructured":"Niebroj-Dobosz I, Janik P, Soko-\u00c7owska B, Kwiecinski H (2010) Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Eur J Neurol 17:226\u2013231","journal-title":"Eur J Neurol"},{"key":"6146_CR25","doi-asserted-by":"crossref","first-page":"9913","DOI":"10.1158\/0008-5472.CAN-06-0377","volume":"66","author":"Y Mitsui","year":"2006","unstructured":"Mitsui Y, Mochizuki S, Kodama T et al (2006) ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growthfactorbindingprotein-3. Cancer Res 66:9913\u20139920","journal-title":"Cancer Res"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6146-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-6146-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6146-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T19:25:18Z","timestamp":1592681118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6146-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["6146"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6146-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,25]]}}}